Dorzolamid + tymolol: interakcje

Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (etykieta leku Alogliptyna + metformina, Ostrzeżenie w ramce)

CONTRAINDICATIONS Atenolol and chlorthalidone is contraindicated in patients with: sinus bradycardia; heart block greater than first degree; cardiogenic shock; overt cardiac failure (See WARNINGS ); anuria; hypersensitivity to this product or to sulfonamide-derived drugs. (etykieta leku Atenolol + chlortalidon, Przeciwwskazania)

Lotensin HCT is also contraindicated in patients who are hypersensitive to benazepril, to any other ACE inhibitor, to hydrochlorothiazide, or to other sulfonamide-derived drugs. (etykieta leku Benazepryl + hydrochlorotiazyd, Przeciwwskazania)

CONTRAINDICATIONS Bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see WARNINGS ), second or third degree AV block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs. (etykieta leku Bisoprolol + hydrochlorotiazyd, Przeciwwskazania)

• In patients who have demonstrated allergic-type reactions to sulfonamides [ see Warnings and Precautions (5.7) ]. (etykieta leku Celekoksyb, Przeciwwskazania)

Because of the hydrochlorothiazide components, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (etykieta leku Chinapryl + hydrochlorotiazyd, Przeciwwskazania)

Therefore, chloroprocaine should not be used in any condition in which a sulfonamide drug is being employed. (etykieta leku Chloroprokaina, Środki ostrożności)

Hypersensitivity to this product or to other sulfonamide-derived drugs. (etykieta leku Chlorotiazyd, Przeciwwskazania)

THALITONE is contraindicated in patients with anuria or hypersensitivity to chlorthalidone or other sulfonamide-derived drugs. (etykieta leku Chlortalidon, Przeciwwskazania)

Cidofovir injection is contraindicated in patients with a history of clinically severe hypersensitivity to probenecid or other sulfa-containing medications. (etykieta leku Cydofowir, Przeciwwskazania)

• Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (etykieta leku Dapagliflozyna + metformina, Ostrzeżenie w ramce)

KEVEYIS is contraindicated in the following circumstances: Hypersensitivity to dichlorphenamide or other sulfonamides [see Warnings and Precautions (5.1) ] Concomitant use of KEVEYIS and high dose aspirin [see Warnings and Precautions (5.2) and Drug Interactions (7.1) ] Severe pulmonary disease, limiting compensation to metabolic acidosis caused by KEVEYIS [see… (etykieta leku Diklofenamid, Przeciwwskazania)

If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin-containing products, including JALYN. (etykieta leku Dutasteryd + tamsulosyna, Ostrzeżenia i środki ostrożności)

Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (etykieta leku Empagliflozyna + metformina, Ostrzeżenie w ramce)

Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (etykieta leku Enalapryl + hydrochlorotiazyd, Przeciwwskazania)

Avoid use of phentermine and topiramate extended-release capsules with other carbonic anhydrase inhibitors. (etykieta leku Fentermina + topiramat, Ostrzeżenia i środki ostrożności)

Concomitant negative chronotropic therapy such as digoxin or beta-blockers may lower the risk of this complication. (etykieta leku Flekainid, Ostrzeżenie w ramce)

Fosinopril sodium and hydrochlorothiazide is also contraindicated in patients who are hypersensitive to fosinopril, to any other ACE inhibitor, to hydrochlorothiazide, or other sulfonamide-derived drugs, or any other ingredient or component in the formulation. (etykieta leku Fozynopryl + hydrochlorotiazyd, Przeciwwskazania)

Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g. , acute congestive heart failure), excessive alcohol intake, hepatic… (etykieta leku Glibenklamid + metformina, Ostrzeżenie w ramce)

• Sulfonamide derivatives: Patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride tablets.Do not use glimepiride tablets in patients who have a history of an allergic reaction to sulfonamide derivatives. (etykieta leku Glimepiryd, Przeciwwskazania)

• Hypersensitivity to sulfonamide derivatives. ▪ Known hypersensitivity to glipizide or any of the product's ingredients ( 4 ). ▪ Hypersensitivity to sulfonamide derivatives ( 4 ). (etykieta leku Glipizyd, Przeciwwskazania)

In patients with hypersensitivity to sulfonamide-derived drugs. (etykieta leku Hydrochlorotiazyd, Przeciwwskazania)

Known hypersensitivity to indapamide or to other sulfonamide-derived drugs. (etykieta leku Indapamid, Przeciwwskazania)

Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (etykieta leku Irbesartan + hydrochlorotiazyd, Przeciwwskazania)

CONTRAINDICATIONS Candesartan cilexetil and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitive to candesartan, to hydrochlorothiazide or to other sulfonamide-derived drugs. (etykieta leku Kandesartan + hydrochlorotiazyd, Przeciwwskazania)

Patients suspected of developing thyrotoxicosis should be managed carefully to avoid abrupt withdrawal of beta-adrenergic blocking agents that might precipitate a thyroid storm. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Patients suspected of developing thyrotoxicosis should be managed carefully to avoid abrupt withdrawal of beta-adrenergic blocking agents that might precipitate a thyroid storm. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (etykieta leku Linagliptyna + metformina, Ostrzeżenie w ramce)

Patients suspected of developing thyrotoxicosis should be managed carefully to avoid abrupt withdrawal of beta-adrenergic blocking agents that might precipitate a thyroid storm. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (etykieta leku Lizynopryl + hydrochlorotiazyd, Przeciwwskazania)

Patients receiving antibiotics and sulfonamides should generally not be treated with ganglion blockers. (etykieta leku Mekamylamina, Przeciwwskazania)

Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, and hepatic… (etykieta leku Metformina, Ostrzeżenie w ramce)

Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (etykieta leku Metoprolol + hydrochlorotiazyd, Przeciwwskazania)

In addition, life-threatening arrhythmias may occur during anesthesia and surgery, and may require treatment with a beta-blocker or lidocaine. (etykieta leku Metyrozyna, Ostrzeżenia)

Minoxidil must be administered under close supervision, usually concomitantly with therapeutic doses of a beta-adrenergic blocking agent to prevent tachycardia and increased myocardial workload. (etykieta leku Minoksydyl, Ostrzeżenie w ramce)

Hypotensive Agents Do not use BYSTOLIC with other β-blockers. (etykieta leku Nebiwolol, Interakcje z innymi lekami)

Because of the hydrochlorothiazide component, olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet is contraindicated in patients with anuria, hypersensitivity to any component, or hypersensitivity to other sulfonamide-derived drugs. (etykieta leku Olmesartan + amlodypina + hydrochlorotiazyd, Przeciwwskazania)

Use in patients with known history of an allergic reaction to sulfonamide derivatives. (etykieta leku Pioglitazon + glimepiryd, Przeciwwskazania)

Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (etykieta leku Pioglitazon + metformina, Ostrzeżenie w ramce)

Patients suspected of developing thyrotoxicosis should be managed carefully to avoid abrupt withdrawal of beta-adrenergic blocking agents that might precipitate a thyroid storm. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Risk factors include high dose or overdose, rapid administration (see WARNINGS and DOSAGE AND ADMINISTRATION ), repeated doses, previous administration of protamine, and current or previous use of protamine-containing drugs (NPH insulin, protamine zinc insulin, and certain beta-blockers). (etykieta leku Protamina, Ostrzeżenie w ramce)

Examples: beta-blockers, clonidine, guanethidine, and reserpine Clopidogrel : Avoid concomitant use; if used concomitantly initiate at 0.5 mg before each meal and limit total daily dose to 4 mg ( 7 ) (etykieta leku Repaglinid, Interakcje z innymi lekami)

Concomitant use with metoclopramide, beta-blockers, or cholinomimetic and anticholinergic drugs is not recommended ( 7.1 , 7.2 , 7.3 ) (etykieta leku Rywastygmina, Interakcje z innymi lekami)

• Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure ), excessive alcohol intake, hepatic… (etykieta leku Saksagliptyna + metformina, Ostrzeżenie w ramce)

CONTRAINDICATIONS Spironolactone and hydrochlorothiazide tablets are contraindicated in patients with anuria, acute renal insufficiency, significant impairment of renal excretory function, hypercalcemia, hyperkalemia, Addison's disease, and in patients who are allergic to thiazide diuretics or to other sulfonamide-derived drugs. (etykieta leku Spironolakton + hydrochlorotiazyd, Przeciwwskazania)

Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic… (etykieta leku Sytagliptyna + metformina, Ostrzeżenie w ramce)

If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (etykieta leku Tamsulosyna, Ostrzeżenia i środki ostrożności)

Patients suspected of developing thyrotoxicosis should be managed carefully to avoid abrupt withdrawal of beta-adrenergic blocking agents that might precipitate a thyroid storm. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Patients suspected of developing thyrotoxicosis should be managed carefully to avoid abrupt withdrawal of beta-adrenergic blocking agents that might precipitate a thyroid storm. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Kidney stones: avoid use with other carbonic anhydrase inhibitors, drugs causing metabolic acidosis, or in patients on a ketogenic diet ( 5.13 ) (etykieta leku Topiramat, Ostrzeżenia i środki ostrożności)

…Syndrome (SS) c ] Agents with blood pressure-reducing effects Use with caution d Hypotension e Non-selective H1 receptor antagonists Contraindicated a Increased anticholinergic effects Beta-adrenergic blockers (see also agents or procedures with blood pressure-reducing effects) Use with the caution d More pronounced bradycardia, postural hypotension e Blood glucose-lowering… (etykieta leku Tranylcypromina, Interakcje z innymi lekami)

Hypersensitivity Hypersensitivity to either drug in the preparation or to other sulfonamide-derived drugs is a contraindication. (etykieta leku Triamteren + hydrochlorotiazyd, Przeciwwskazania)

Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (etykieta leku Walsartan + hydrochlorotiazyd, Przeciwwskazania)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Because of possible additive effects with other carbonic anhydrase inhibitors, concomitant use is not advisable. (etykieta leku Acetazolamid, Interakcje z innymi lekami)

Such patients may be unresponsive to the usual doses of epinephrine used to treat anaphylactic reactions. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Use with caution in patients with a known hypersensitivity to sulfonamides ( 5.8 ) (etykieta leku Almotryptan, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Beta-blockers may decrease effectiveness. (etykieta leku Arformoterol, Interakcje z innymi lekami)

Such patients may be unresponsive to the usual doses of epinephrine used to treat anaphylactic reactions. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Therefore, CYCLOSET may increase the unbound fraction of other concomitantly used highly protein-bound therapies (e.g., salicylates, sulfonamides, chloramphenicol and probenecid), which may alter their effectiveness and risk for side effects. (etykieta leku Bromokryptyna, Interakcje z innymi lekami)

Beta-blockers: Use with caution. (etykieta leku Budezonid + formoterol, Interakcje z innymi lekami)

Risk of Hypertension and Bradycardia Due to Drug Interactions Between MARCAINE WITH EPINEPHRINE and Nonselective Beta-Adrenergic Antagonists Administration of MARCAINE WITH EPINEPHRINE (containing a vasoconstrictor) in patients receiving nonselective beta-adrenergic antagonists may cause severe hypertension and bradycardia. (etykieta leku Bupiwakaina, Ostrzeżenia i środki ostrożności)

Such patients may be unresponsive to the usual doses of epinephrine used to treat anaphylactic reactions. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (etykieta leku Cewimelina, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

CYP2D6 Inhibitors Potentiated systemic beta-blockade (e.g., decreased heart rate, depression) has been reported during combined treatment with CYP2D6 inhibitors (e.g., quinidine, SSRIs) and timolol. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Catecholamine-Depleting Drugs Close observation of the patient is recommended when a beta-blocker is administered to patients receiving catecholamine-depleting drugs such as reserpine, because of possible additive effects and the production of hypotension and/or marked bradycardia, which may result in vertigo, syncope, or postural hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Digitalis and calcium antagonists may have additive effects in prolonging atrioventricular conduction time. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Beta Blockers Although the results of a clinical study did not indicate a safety problem associated with the administration of Dihydroergotamine Mesylate Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine. (etykieta leku Dihydroergotamina, Interakcje z innymi lekami)

Intervention: During concomitant use of ZIPSOR and ACE-inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Diklofenak, Interakcje z innymi lekami)

• During concomitant use of diclofenac sodium/misoprostol and ACE inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Diklofenak + mizoprostol, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Concomitant medications were grouped as ACE inhibitors, oral anticoagulants, calcium channel blockers, beta blockers, cardiac glycosides, inducers of CYP3A4, substrates and inhibitors of CYP3A4, substrates and inhibitors of P-glycoprotein, nitrates, sulphonylureas, loop diuretics, potassium sparing diuretics, thiazide diuretics, substrates and inhibitors of tubular… (etykieta leku Dofetylid, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Give a low dose of beta-blockers initially, and increase only after ECG verification of good tolerability [see Drug Interactions (7.3) , Clinical Pharmacology (12.3) ] . (etykieta leku Dronedaron, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine tablets by blocking the vasodilating property of epinephrine. (etykieta leku Ergotamina + kofeina, Interakcje z innymi lekami)

CYP2D6 Inhibitors Potentiated systemic beta-blockade (e.g., decreased heart rate, depression) has been reported during combined treatment with CYP2D6 inhibitors (e.g., quinidine, SSRIs) and timolol. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

…hydrochloride desipramine hydrochloride imipramine hydrochloride doxepin carbamazepine cyclobenzaprine HCl amoxapine maprotiline HCl trimipramine maleate protriptyline HCl mirtazapine Phenelzine sulfate should be used with caution in combination with antihypertensive drugs, including thiazide diuretics and β-blockers, since exaggerated hypotensive effects may result. (etykieta leku Fenelzyna, Ostrzeżenia)

Intervention: Patients receiving hydantoins, sulfonamides, or sulfonylureas should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs. (etykieta leku Fenoprofen, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

…voriconazole Antineoplastic agents Capecitabine, fluorouracil Antidepressants Fluoxetine, fluvoxamine, sertraline Gastric acid reducing agents H 2 antagonists (cimetidine), omeprazole Sulfonamides Sulfamethizole, sulfaphenazole, sulfadiazine, sulfamethoxazole-trimethoprim Other Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen,… (etykieta leku Fenytoina, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Intervention: During concomitant use of flurbiprofen and ACE-inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Flurbiprofen, Interakcje z innymi lekami)

CYP2D6 Inhibitors Potentiated systemic beta-blockade (e.g., decreased heart rate, depression) has been reported during combined treatment with CYP2D6 inhibitors (e.g., quinidine, SSRIs) and timolol. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

• Beta-blockers may decrease effectiveness. (etykieta leku Formoterol, Interakcje z innymi lekami)

Fosamprenavir calcium should be used with caution in patients with a known sulfonamide allergy. (etykieta leku Fosamprenawir, Ostrzeżenia i środki ostrożności)

…voriconazole Antineoplastic agents Capecitabine, fluorouracil Antidepressants Fluoxetine, fluvoxamine, sertraline Gastric acid reducing agents H 2 antagonists (cimetidine), omeprazole Sulfonamides Sulfamethizole, sulfaphenazole, sulfadiazine, sulfamethoxazole-trimethoprim Other Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen,… (etykieta leku Fosfenytoina, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Table 4: Clinically Significant Drug Interaction with GVOKE and GVOKE VialDx Beta-Blockers Clincial Impact: Patients taking beta-blockers may have a transient increase in pulse and blood pressure when given GVOKE or GVOKE VialDx. (etykieta leku Glukagon, Interakcje z innymi lekami)

During concomitant use of hydrocodone bitartrate and ibuprofen tablets and ACE-inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Hydrokodon + ibuprofen, Interakcje z innymi lekami)

Intervention: During concomitant use of CALDOLOR and ACE-inhibitors, ARBs, or beta- blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Ibuprofen, Interakcje z innymi lekami)

Intervention: During concomitant use of ibuprofen and famotidine tablet and ACE-inhibitors, ARBs, or beta- blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Ibuprofen + famotydyna, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Intervention: During concomitant use of INDOCIN and ACE-inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Indometacyna, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Beta Blockers Nadolol Monitor for adverse reactions. (etykieta leku Itrakonazol, Interakcje z innymi lekami)

The risk of bradycardia increases with concomitant administration of drugs that slow heart rate (e.g., digoxin, amiodarone, beta-blockers). (etykieta leku Iwabradyna, Interakcje z innymi lekami)

Concomitant Use with Beta Blockers Concomitant use of beta blockers may exaggerate the cardiovascular effects of inhalational anesthetics, including hypotension and negative inotropic effects. (etykieta leku Izofluran, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

As with other β-blockers, if COREG is administered with calcium channel blockers of the verapamil or diltiazem type, it is recommended that ECG and blood pressure be monitored. (etykieta leku Karwedilol, Interakcje z innymi lekami)

Antivirals indinavir, maraviroc, saquinavir Beta Blockers nadolol Calcium Channel Blockers felodipine, nisoldipine other dihydropyridines, verapamil Calcium channel blockers can have a negative inotropic effect which may be additive to those of ketoconazole. (etykieta leku Ketokonazol, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Abrupt discontinuation of QLONILIK can cause rebound hypertension with elevated plasma catecholamines, especially with higher doses or concomitant beta-blocker use. (etykieta leku Klonidyna, Ostrzeżenia i środki ostrożności)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Intervention: During concomitant use of mefenamic acid and ACE-inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Kwas mefenamowy, Interakcje z innymi lekami)

VIMPAT should also be used with caution in patients on concomitant medications that affect cardiac conduction, including sodium channel blockers, beta-blockers, calcium channel blockers, potassium channel blockers, and medications that prolong the PR interval [see Drug Interactions (7.2) ] . (etykieta leku Lakozamid, Ostrzeżenia i środki ostrożności)

Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etykieta leku Lanreotyd, Interakcje z innymi lekami)

Patients also taking beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease, may be at increased risk for symptomatic bradycardia with coadministration of amiodarone. (etykieta leku Ledipaswir + sofosbuwir, Ostrzeżenia i środki ostrożności)

In this setting, cardioselective beta-blockers should be considered, although they should be administered with caution. (etykieta leku Lewosalbutamol, Interakcje z innymi lekami)

Such patients may be unresponsive to the usual doses of epinephrine used to treat anaphylactic reactions. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (etykieta leku Losartan + hydrochlorotiazyd, Ostrzeżenia i środki ostrożności)

There is one report of cardiopulmonary arrest, with full recovery, in a patient who was taking a beta blocker (propranolol) (see PRECAUTIONS, Cardiac Effects ). (etykieta leku Meflochina, Interakcje z innymi lekami)

Intervention: During concomitant use of QAMZOVA and ACE-inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Meloksykam, Interakcje z innymi lekami)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

…procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine (etykieta leku Mepiwakaina, Interakcje z innymi lekami)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Beta-blockers Caution should be exercised when methylergonovine maleate is used concurrently with beta-blockers. (etykieta leku Metyloergometryna, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (etykieta leku Motixafortide, Ostrzeżenia i środki ostrożności)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Intervention: During concomitant use of Naproxen Suspension and ACE-inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Naproksen, Interakcje z innymi lekami)

Intervention : • During concomitant use of naproxen and esomeprazole magnesium delayed-release tablets and ACE-inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Naproksen + ezomeprazol, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Antihypertensives Patients receiving antihypertensive drugs, beta-adrenergic blockers, and nitrates should be observed for possible additive hypotensive effects. (etykieta leku Nitrogliceryna, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Intervention: During concomitant use of OXAPROZIN CAPSULES and ACE inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Oksaprozyna, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Dosage adjustments of concomitantly used drugs that have bradycardia effects (i.e. beta-blockers) may be necessary [see Drug Interactions (‎7.2) ]. (etykieta leku Oktreotyd, Ostrzeżenia i środki ostrożności)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (etykieta leku Olmesartan + hydrochlorotiazyd, Ostrzeżenia i środki ostrożności)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Intervention: • During concomitant use of COMBOGESIC and ACE-inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Paracetamol + ibuprofen, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Adjustments in the dose of drugs known to slow the heart rate (e.g., beta-blockers, calcium channel blockers) and correction of electrolyte disturbances may be necessary when initiating or during the course of SIGNIFOR LAR treatment. (etykieta leku Pasyreotyd, Ostrzeżenia i środki ostrożności)

Drug Interactions Pilocarpine should be administered with caution to patients taking beta-adrenergic antagonists because of the possibility of conduction disturbances. (etykieta leku Pilokarpina, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Intervention: • During concomitant use of Piroxicam Capsules and ACE inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained. (etykieta leku Piroksykam, Interakcje z innymi lekami)

Use with caution in persons with increased risk of anticholinergic reactions, such as persons with bronchial asthma, chronic obstructive pulmonary disease, bradycardia, cardiac arrhythmias, beta blocker treatment (increased risk of anticholinergic reactions). (etykieta leku Pirydostygmina, Ostrzeżenia i środki ostrożności)

However, the concomitant use of other antifolic drugs or agents associated with myelosuppression including sulfonamides or trimethoprim- sulfamethoxazole combinations, proguanil, zidovudine, or cytostatic agents (e.g., methotrexate), while the patient is receiving pyrimethamine, may increase the risk of bone marrow suppression. (etykieta leku Pirymetamina, Interakcje z innymi lekami)

Experience with PONVORY is limited in patients receiving concurrent therapy with drugs that decrease heart rate (e.g., beta-blockers, non-dihydropyridine calcium channel blockers - diltiazem and verapamil, and other drugs that may decrease heart rate such as digoxin). (etykieta leku Ponesimod, Ostrzeżenia i środki ostrożności)

Hypotension may develop in patients given prazosin hydrochloride capsules who are also receiving a beta-blocker such as propranolol. (etykieta leku Prazosyna, Ostrzeżenia)

Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (etykieta leku Probenecyd, Interakcje z innymi lekami)

Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (etykieta leku Probenecyd + kolchicyna, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Such patients may be unresponsive to the usual doses of epinephrine used to treat anaphylactic reactions. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Patients on beta-blockers may not manifest changes in heart rate, but blood pressure monitoring can detect a rise in systolic blood pressure. (etykieta leku Ropiwakaina, Ostrzeżenia i środki ostrożności)

Decrease exposure Beta-blockers Metoprolol Decrease exposure Propranolol Decrease exposure Benzodiazepines Diazepam , Administered with rifampin 1200 mg daily Decrease exposure Benzodiazepine-related drugs Zopiclone Decrease AUC by 82% Zolpidem Decrease AUC by 73% Calcium Channel Blockers Diltiazem Decrease exposure Nifedipine Rifampin 1200 mg administered as… (etykieta leku Ryfampicyna, Interakcje z innymi lekami)

…Anticonvulsants Phenytoin Antimalarials Quinine Azole Antifungals Fluconazole, itraconazole, ketoconazole Antipsychotics Haloperidol Barbiturates Phenobarbital Benzodiazepines Diazepam Beta-Blockers Propranolol Calcium Channel Blockers Diltiazem, nifedipine, verapamil Cardiac Glycoside Preparations Digoxin Corticosteroids Prednisone Fibrates Clofibrate Oral Hypoglycemics… (etykieta leku Ryfapentyna, Interakcje z innymi lekami)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Beta-blockers: Use with caution. (etykieta leku Salbutamol, Interakcje z innymi lekami)

• Beta-blockers: Use with caution. (etykieta leku Salmeterol, Interakcje z innymi lekami)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

CYP2D6 Inhibitors Potentiated systemic beta-blockade (e.g., decreased heart rate, depression) has been reported during combined treatment with CYP2D6 inhibitors (e.g., quinidine, SSRIs) and timolol. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Patients also taking beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease may be at increased risk for symptomatic bradycardia with coadministration of amiodarone. (etykieta leku Sofosbuwir + welpataswir, Ostrzeżenia i środki ostrożności)

Like other sulfonamide-containing drugs, sulfamethoxazole and trimethoprim potentiates the effect of oral hypoglycemics. (etykieta leku Sulfametoksazol + trimetoprim, Interakcje z innymi lekami)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Intervention: During concomitant use of sumatriptan and naproxen sodium tablets and ACE-inhibitors, ARBs, or beta-blockers, monitor blood pressure to ensure that the desired blood pressure is obtained [see Warnings and Precautions (5.8)] . (etykieta leku Sumatryptan + naproksen, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (etykieta leku Telmisartan + hydrochlorotiazyd, Ostrzeżenia i środki ostrożności)

CYP2D6 inhibitors may potentiate systemic beta-blockade. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

In this setting, cardioselective beta-blockers could be considered, although they should be administered with caution. (etykieta leku Terbutalina, Środki ostrożności)

Catecholamine-Depleting Drugs Close observation of the patient is recommended when a beta-blocker is administered to patients receiving catecholamine-depleting drugs such as reserpine, because of possible additive effects and the production of hypotension and/or marked bradycardia, which may result in vertigo, syncope, or postural hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Masking of Hypoglycemic Symptoms in Patients with Diabetes Mellitus Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

• Beta-blockers: Use with caution. (etykieta leku Umeklidynium + wilanterol, Interakcje z innymi lekami)

Catecholamine-Depleting Drugs Close observation of the patient is recommended when a beta-blocker is administered to patients receiving catecholamine-depleting drugs such as reserpine, because of possible additive effects and the production of hypotension and/or marked bradycardia, which may result in vertigo, syncope, or postural hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Oral or intravenous calcium antagonists may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etykieta leku Dorzolamid + tymolol, Ostrzeżenia i środki ostrożności)

CYP2D6 Inhibitors Potentiated systemic beta-blockade (e.g., decreased heart rate, depression) has been reported during combined treatment with CYP2D6 inhibitors (e.g., quinidine, SSRIs) and timolol. (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy). (etykieta leku Dorzolamid + tymolol, Interakcje z innymi lekami)

Zileuton increases propranolol levels and beta-blocker activity. (etykieta leku Zileuton, Interakcje z innymi lekami)

• Concomitant use of ZONISADE with any other carbonic anhydrase inhibitor may increase the severity of metabolic acidosis and may also increase the risk of kidney stone formation ( 7.2 ). (etykieta leku Zonisamid, Interakcje z innymi lekami)

Effects of Adenosine on Other Drugs Adenosine injection has been given with other cardioactive drugs (such as beta adrenergic blocking agents, cardiac glycosides, and calcium channel blockers) without apparent adverse interactions, but its effectiveness with these agents has not been systematically evaluated. (etykieta leku Adenozyna, Interakcje z innymi lekami)

Other Antibacterials Chloramphenicol, macrolides, sulfonamides, and tetracyclines may interfere with the bactericidal effects of penicillin. (etykieta leku Amoksycylina, Interakcje z innymi lekami)

Bacteriostatic Antibiotics : Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins. (etykieta leku Ampicylina, Interakcje z innymi lekami)

As with other beta-blockers, when discontinuation of TENORMIN is planned, the patients should be carefully observed and advised to limit physical activity to a minimum. (etykieta leku Atenolol, Ostrzeżenia)

Drug Interactions Bacteriostatic antibacterials ( i.e. , chloramphenicol, erythromycins, sulfonamides or tetracyclines) may antagonize the bactericidal effect of penicillin, and concurrent use of these drugs should be avoided. (etykieta leku Benzylopenicylina, Interakcje z innymi lekami)

Drug Interactions BISOPROLOL FUMARATE should not be combined with other beta-blocking agents. (etykieta leku Bisoprolol, Interakcje z innymi lekami)

Lack of Effectiveness Methemoglobinemia may not resolve or may rebound after response to treatment with PROVAYBLUE in patients with methemoglobinemia due to aryl amines such as aniline or sulfa drugs such as dapsone. (etykieta leku Błękit metylenowy, Ostrzeżenia i środki ostrożności)

Allergy to Sulfonamides Patients allergic to sulfonamides may show hypersensitivity to bumetanide. (etykieta leku Bumetanid, Ostrzeżenia)

Other Cardiovascular Agents Enalaprilat injection, USP has been used concomitantly with digitalis, beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine and prazosin without evidence of clinically significant adverse interactions. (etykieta leku Enalaprylat, Interakcje z innymi lekami)

…PROSCAR was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines,… (etykieta leku Finasteryd, Interakcje z innymi lekami)

Drugs That Slow Heart Rate or Atrioventricular Conduction (e.g., beta blockers or diltiazem) Experience with GILENYA in patients receiving concurrent therapy with drugs that slow the heart rate or AV conduction (e.g., beta blockers, digoxin, or heart rate-slowing calcium channel blockers, such as diltiazem or verapamil) is limited. (etykieta leku Fingolimod, Interakcje z innymi lekami)

CNS depressants include: alcohol, opioid analgesics, benzodiazepines, tricyclic antidepressants, sedative/hypnotics, anticonvulsants, antipsychotics, antihistamines, anticholinergics, alpha and beta blockers, general anesthetics, muscle relaxants, and illicit CNS depressants. (etykieta leku Karbamazepina, Interakcje z innymi lekami)

Effects on the absorption of other beta-blockers have not been determined. (etykieta leku Kolestypol, Interakcje z innymi lekami)

Urine pH is altered by diet, drugs (e.g. carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g. renal tubular acidosis or severe infections of the urinary tract). (etykieta leku Memantyna, Interakcje z innymi lekami)

Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract). (etykieta leku Memantyna + donepezyl, Interakcje z innymi lekami)

Cross-Allergy Cross-allergy may occur when metolazone tablets, USP, are given to patients known to be allergic to sulfonamide-derived drugs, thiazides, or quinethazone. (etykieta leku Metolazon, Ostrzeżenia)

Pentoxifylline extended-release tablets have been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, and antiarrhythmics, without observed problems. (etykieta leku Pentoksyfilina, Interakcje z innymi lekami)

Drug Interactions Metabolism of a number of medications, including antipsychotics, antidepressants, β-blockers, and antiarrhythmics, occurs through the cytochrome P450 2D6 isoenzyme (debrisoquine hydroxylase). (etykieta leku Perfenazyna, Interakcje z innymi lekami)

There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. (etykieta leku Sulfadiazyna srebrowa, Ostrzeżenia i środki ostrożności)

Angiotensin Receptor Blockers, Angiotensin Converting Enzyme Inhibitors and Potassium Sparing Diuretics Although specific interaction studies were not performed, in clinical studies, tolvaptan was used concomitantly with beta-blockers, angiotensin receptor blockers, angiotensin converting enzyme inhibitors and potassium sparing diuretics. (etykieta leku Tolwaptan, Interakcje z innymi lekami)

Beta-adrenergic blocking agents: Coadministration of beta-adrenergic blocking agents did not have any effect on either the safety or efficacy of ibutilide in the clinical trials. (etykieta leku Ibutylid, Interakcje z innymi lekami)